InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Galson Steven K, 董事. Director active across 1 company, notably Biocryst Pharmaceuticals INC. Cumulatively, 5 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €112k. Activity tracked since 7 June 2022. The latest transaction was disclosed on 12 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Steven K. Galson is a Director at BIOCRYST PHARMACEUTICALS INC. He contributes to corporate governance and the strategic direction of the company. As a board member, he participates in important decision-making and oversight of BIOCRYST's operations. His experience in the biopharmaceutical sector is an asset for the company.